newsfilter
← Latest News
Business Wire·

Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM

Data on >1,100 patients presented at the World Conference on Lung Cancer shows Signatera MRD status strongly predicted recurrence-free and overall survival in resected non-small cell lung cancer, with findings